Dream Pharma in deal with Laboratoires SMB

Published: 2007-11-06 06:57:00

Updated: 2007-11-06 06:57:00

Dream Pharma has entered into an exclusive licensing agreement with Begiumbased Laboratoires SMB S.A., for its asthma product 'BUSAL', said a company spokesperson on October 31.

The inhaler contains a mixture of a bronchodilator and steroid using HPMC capsule and AXAHALER D.P.I. (dry powder in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK